查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1671061

中樞神經系統藥物市場、規模、佔有率、趨勢、行業分析報告（依疾病、藥物類別、通路和地區）- 市場預測2025-2034

Central Nervous System Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Disease, Drug Class, Distribution Channel, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 125 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的一項新研究，全球中樞神經系統藥物市場預計到2034年將達到 3,812.7億美元。本研究報告對當前市場動態提供了詳細的見解，並對未來市場成長進行了分析。

中樞神經系統（CNS）治療市場包括治療阿茲海默症、帕金森氏症、癲癇和憂鬱症等神經系統疾病的藥物和治療，重點是改善大腦和脊髓的健康和功能。

由於腦腫瘤和神經膠質瘤等中樞神經系統癌症的發生率不斷增加，中樞神經系統（CNS）藥物市場日益擴大。診斷數量的增加推動了對有效治療的需求。例如，美國腦瘤協會報告指出，美國每年有 9萬人被診斷出患有原發性腦瘤，病例呈現成長趨勢。此外，老化也是中樞神經系統癌症增加的原因之一，因為老年人更容易受到致癌輻射的影響。

中樞神經系統（CNS）藥物市場的成長受到政府在醫療保健方面支出增加的推動。政府和私營部門都在增加對醫療保健的投資，更加重視開發針對憂鬱症、焦慮症和阿茲海默症等中樞神經系統疾病的有效治療方法。例如，根據世界銀行集團的資料，2021年醫療保健支出佔GDP總量的10.3%。這些資金支持促進了研究和創新，推出了具有成本效益的治療方法。

由於先進的診斷技術使得識別神經系統疾病變得更加容易，中樞神經系統藥物市場蓬勃發展。這些進步使得診斷更加早期、更準確，增加了對有效治療的需求。

中樞神經系統治療市場報告重點

根據藥物類別，由於注意力不足過動症（ADHD）和睡眠障礙的盛行率不斷上升，中樞神經系統興奮劑領域預計將出現顯著成長，在全球市場上呈現高年複合成長率。

依通路劃分，由於因阿茲海默症和帕金森氏症等神經退化性疾病住院患者數量增加，醫院藥房部門在2024年佔據了中樞神經系統藥物市場的主導地位。

在2024年的中樞神經系統藥物市場中，由於阿茲海默症患者病率的上升，北美佔據了最大的收入佔有率。

由於製藥業的擴張，印度中樞神經系統藥物市場預計將大幅成長。

全球市場的一些主要參與者包括Biogen、Otsuka Pharmaceutical Co., Ltd.、Eli Lilly and Company、Merck & Co., Inc.、Astra Zeneca、Takeda Pharmaceutical Company Limited、Novartis AG、Teva Pharmaceutical Industries Ltd、Johnson & Johnson, Inc.、Pfizer Inc. 。

目錄

第1章 簡介

第2章 執行摘要

第3章 研究方法

第4章 全球中樞神經系統藥物市場洞察

  • 市場概況
  • 中樞神經系統藥物市場動態
    • 驅動因素和機會
      • 老年人口增加將推動市場成長
      • 對心理健康的投資增加推動市場規模擴大
    • 阻礙因素和挑戰
      • 監理障礙
  • PESTEL 分析
  • 中樞神經系統藥物的市場趨勢
  • 價值鏈分析
  • COVID-19 影響分析

第5章 全球中樞神經系統藥物市場（依疾病類型）

  • 主要調查結果
  • 簡介
  • 神經血管疾病
  • 中樞神經系統創傷
  • 心理健康
  • 神經退化性疾病
  • 傳染病
  • 中樞神經系統癌症
  • 其他

第6章 全球中樞神經系統藥物市場（依藥物類別）

  • 主要調查結果
  • 簡介
  • 麻醉藥物
  • 抗驚厥藥
  • 止吐藥
  • 中樞神經系統興奮劑
  • 止痛藥
  • 其他

第7章 全球中樞神經系統藥物市場（依通路）

  • 主要調查結果
  • 簡介
  • 醫院藥房
  • 零售藥局
  • 其他

第8章 全球中樞神經系統治療市場（依地區）

  • 主要調查結果
  • 簡介
    • 中樞神經系統治療市場評估：地區，2020年至2034年
  • 北美洲
    • 依疾病類型，2020年至2034年
    • 依藥物類別，2020年至2034年
    • 依通路，2020年至2034年
    • 美國
    • 加拿大
  • 歐洲
    • 依疾病類型，2020年至2034年
    • 依藥物類別，2020年至2034年
    • 依通路，2020年至2034年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 依疾病類型，2020年至2034年
    • 依藥物類別，2020年至2034年
    • 依通路，2020年至2034年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東和非洲
    • 依疾病類型，2020年至2034年
    • 依藥物類別，2020年至2034年
    • 依通路，2020年至2034年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲地區
  • 拉丁美洲
    • 依疾病類型，2020年至2034年
    • 依藥物類別，2020年至2034年
    • 依通路，2020年至2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家

第9章 競爭格局

  • 擴張與收購分析
    • 擴張
    • 收購
  • 夥伴關係/協作/協議/公開

第10章 公司簡介

  • Biogen
  • Otsuka Pharmaceutical Co., Ltd.
  • Eli Lilly and Company
  • Merck & Co., Inc.
  • Astra Zeneca
  • Takeda Pharmaceutical Company Limited
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd
  • Johnson & Johnson, Inc.
  • Pfizer Inc.
Product Code: PM5368

The global central nervous system therapeutics market size is expected to reach USD 381.27 billion by 2034, according to a new study by Polaris Market Research. The report "Central Nervous System Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Disease, Drug Class, Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The central nervous system (CNS) therapeutics market encompasses drugs and treatments for neurological disorders like Alzheimer's, Parkinson's, epilepsy, and depression, focusing on improving brain and spinal cord health and function.

The central nervous system (CNS) therapeutics market is expanding due to the growing incidence of CNS cancers, including brain tumors, gliomas, and other types. The increasing number of diagnoses is driving demand for effective treatments. For example, the American Brain Tumor Association reports that 90,000 people in the US are diagnosed with a primary brain tumor each year, reflecting a rising trend in cases. Additionally, the aging population is contributing to the increase in CNS cancer cases, as older adults are more vulnerable to cancer-causing radiation.

The central nervous system (CNS) therapeutics market growth is being driven by increased government spending on healthcare. Both governments and private sectors are investing more in healthcare, which has led to a stronger focus on developing effective treatments for CNS disorders such as depression, anxiety, and Alzheimer's disease. For example, healthcare expenditure in 2021 accounted for 10.3% of total GDP, according to the World Bank Group. This financial support has fostered research and innovation, resulting in the introduction of cost-effective therapies.

The central nervous system therapeutics market is growing due to advanced diagnostic technologies that make it easier to identify neurological disorders. These advancements lead to earlier and more accurate diagnoses and lead to an increased demand for effective treatments.

Central Nervous System Therapeutics Market Report Highlights

Based on drug class, the CNS stimulants segment is expected to experience significant growth with a high CAGR in the global market due to the rising prevalence of attention deficit hyperactivity (ADHD) and sleep disorders.

By distribution channel, the hospital pharmacies segment dominated the central nervous system therapeutics market in 2024 due to the rising number of hospital admissions for neurodegenerative diseases, such as Alzheimer's and Parkinson's.

In 2024, North America had the largest revenue share in the central nervous system therapeutics market due to the rising prevalence of Alzheimer's disease.

The central nervous system therapeutics market in India is projected for substantial growth, driven by the growth of the pharmaceutical industry.

A few of the global key market players are Biogen; Otsuka Pharmaceutical Co., Ltd.; Eli Lilly and Company; Merck & Co., Inc.; Astra Zeneca; Takeda Pharmaceutical Company Limited; Novartis AG; Teva Pharmaceutical Industries Ltd; Johnson & Johnson, Inc.; and Pfizer Inc.

Polaris market research has segmented the central nervous system therapeutics market report on the basis of disease, drug class, distribution channel, and region:

By Disease Outlook (Revenue - USD Billion, 2020-2034)

  • § Neurovascular Diseases
  • § CNS Trauma
  • § Mental Health
  • § Neurodegenerative Diseases
  • § Alzheimer's Disease
  • § Parkinson's Disease
  • § Multiple Sclerosis
  • § Huntington's Disease
  • § Amyotrophic Lateral Sclerosis
  • § Others
  • § Infectious Diseases
  • § CNS Cancer
  • § Others

By Drug Class Outlook (Revenue - USD Billion, 2020-2034)

  • § Anesthetics
  • § Anticonvulsants
  • § Antiemetics
  • § CNS Stimulants
  • § Pain Relievers
  • § Others

By Distribution Channel Outlook (Revenue - USD Billion, 2020-2034)

  • § Hospital Pharmacies
  • § Retail Pharmacies
  • § Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Central Nervous System Therapeutics Market Insights

  • 4.1. Central Nervous System Therapeutics Market - Market Snapshot
  • 4.2. Central Nervous System Therapeutics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Geriatric Population is Driving Market Growth
      • 4.2.1.2. Increase in Investment in Mental Health is Propelling Market Size
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Regulatory Hurdle
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Central Nervous System Therapeutics Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Central Nervous System Therapeutics Market, by Disease

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • 5.3. Neurovascular Disease
    • 5.3.1. Global Central Nervous System Therapeutics Market, by Neurovascular Disease, by Region, 2020-2034 (USD million)
  • 5.4. CNS Trauma
    • 5.4.1. Global Central Nervous System Therapeutics Market, by CNS Trauma, by Region, 2020-2034 (USD million)
  • 5.5. Mental Health
    • 5.5.1. Global Central Nervous System Therapeutics Market, by Mental Health, by Region, 2020-2034 (USD million)
  • 5.6. Neurodegenerative Diseases
    • 5.6.1. Global Central Nervous System Therapeutics Market, by Neurodegenerative Diseases, by Region, 2020-2034 (USD million)
    • 5.6.2. Alzheimer's Disease
      • 5.6.2.1. Global Central Nervous System Therapeutics Market, by Alzheimer's Disease, by Region, 2020-2034 (USD million)
    • 5.6.3. Parkinsosn's Disease
      • 5.6.3.1. Global Central Nervous System Therapeutics Market, by Parkinsosn's Disease, by Region, 2020-2034 (USD million)
    • 5.6.4. Multiple Sclerosis
      • 5.6.4.1. Global Central Nervous System Therapeutics Market, by Multiple Sclerosis, by Region, 2020-2034 (USD million)
    • 5.6.5. Huntington's Disease
      • 5.6.5.1. Global Central Nervous System Therapeutics Market, by Huntington's Disease, by Region, 2020-2034 (USD million)
    • 5.6.6. Amytrophic Lateral Sclerosis
      • 5.6.6.1. Global Central Nervous System Therapeutics Market, by Amytrophic Lateral Sclerosis, by Region, 2020-2034 (USD million)
    • 5.6.7. Others
      • 5.6.7.1. Global Central Nervous System Therapeutics Market, by Others, by Region, 2020-2034 (USD million)
  • 5.7. Infectious Diseases
    • 5.7.1. Global Central Nervous System Therapeutics Market, by Infectious Diseases, by Region, 2020-2034 (USD million)
  • 5.8. CNS Cancer
    • 5.8.1. Global Central Nervous System Therapeutics Market, by CNS Cancer, by Region, 2020-2034 (USD million)
  • 5.9. Others
    • 5.9.1. Global Central Nervous System Therapeutics Market, by Others, by Region, 2020-2034 (USD million)

6. Global Central Nervous System Therapeutics Market, by Drug Class

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • 6.3. Anesthetics
    • 6.3.1. Global Central Nervous System Therapeutics Market, by Anesthetics, by Region, 2020-2034 (USD million)
  • 6.4. Anticonvulsants
    • 6.4.1. Global Central Nervous System Therapeutics Market, by Anticonvulsants, by Region, 2020-2034 (USD million)
  • 6.5. Antiemetics
    • 6.5.1. Global Central Nervous System Therapeutics Market, by Antiemetics, by Region, 2020-2034 (USD million)
  • 6.6. CNS Stimulants
    • 6.6.1. Global Central Nervous System Therapeutics Market, by CNS Stimulants, by Region, 2020-2034 (USD million)
  • 6.7. Pain Relievers
    • 6.7.1. Global Central Nervous System Therapeutics Market, by Pain Relievers, by Region, 2020-2034 (USD million)
  • 6.8. Others
    • 6.8.1. Global Central Nervous System Therapeutics Market, by Others, by Region, 2020-2034 (USD million)

7. Global Central Nervous System Therapeutics Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • 7.3. Hospital Pharmacies
    • 7.3.1. Global Central Nervous System Therapeutics Market, by Hospital Pharmacies, by Region, 2020-2034 (USD million)
  • 7.4. Retail Pharmacies
    • 7.4.1. Global Central Nervous System Therapeutics Market, by Retail Pharmacies, by Region, 2020-2034 (USD million)
  • 7.5. Others
    • 7.5.1. Global Central Nervous System Therapeutics Market, by Others, by Region, 2020-2034 (USD million)

8. Global Central Nervous System Therapeutics Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Central Nervous System Therapeutics Market Assessment, By Geography, 2020-2034 (USD million)
  • 8.3. Central Nervous System Therapeutics Market - North America
    • 8.3.1. North America: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
    • 8.3.2. North America: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
    • 8.3.3. North America: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.3.4. Central Nervous System Therapeutics Market - U.S.
      • 8.3.4.1. U.S.: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.3.4.2. U.S.: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.3.4.3. U.S.: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.3.5. Central Nervous System Therapeutics Market - Canada
      • 8.3.5.1. Canada: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.3.5.2. Canada: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.3.5.3. Canada: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • 8.4. Central Nervous System Therapeutics Market - Europe
    • 8.4.1. Europe: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
    • 8.4.2. Europe: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
    • 8.4.3. Europe: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.4.4. Central Nervous System Therapeutics Market - UK
      • 8.4.4.1. UK: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.4.4.2. UK: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.4.4.3. UK: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.4.5. Central Nervous System Therapeutics Market - France
      • 8.4.5.1. France: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.4.5.2. France: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.4.5.3. France: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.4.6. Central Nervous System Therapeutics Market - Germany
      • 8.4.6.1. Germany: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.4.6.2. Germany: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.4.6.3. Germany: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.4.7. Central Nervous System Therapeutics Market - Italy
      • 8.4.7.1. Italy: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.4.7.2. Italy: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.4.7.3. Italy: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.4.8. Central Nervous System Therapeutics Market - Spain
      • 8.4.8.1. Spain: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.4.8.2. Spain: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.4.8.3. Spain: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.4.9. Central Nervous System Therapeutics Market - Netherlands
      • 8.4.9.1. Netherlands: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.4.9.2. Netherlands: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.4.9.3. Netherlands: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.4.10. Central Nervous System Therapeutics Market - Russia
      • 8.4.10.1. Russia: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.4.10.2. Russia: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.4.10.3. Russia: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.4.11. Central Nervous System Therapeutics Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.4.11.2. Rest of Europe: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.4.11.3. Rest of Europe: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • 8.5. Central Nervous System Therapeutics Market - Asia Pacific
    • 8.5.1. Asia Pacific: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
    • 8.5.2. Asia Pacific: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
    • 8.5.3. Asia Pacific: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.5.4. Central Nervous System Therapeutics Market - China
      • 8.5.4.1. China: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.5.4.2. China: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.5.4.3. China: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.5.5. Central Nervous System Therapeutics Market - India
      • 8.5.5.1. India: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.5.5.2. India: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.5.5.3. India: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.5.6. Central Nervous System Therapeutics Market - Malaysia
      • 8.5.6.1. Malaysia: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.5.6.2. Malaysia: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.5.6.3. Malaysia: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.5.7. Central Nervous System Therapeutics Market - Japan
      • 8.5.7.1. Japan: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.5.7.2. Japan: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.5.7.3. Japan: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.5.8. Central Nervous System Therapeutics Market - Indonesia
      • 8.5.8.1. Indonesia: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.5.8.2. Indonesia: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.5.8.3. Indonesia: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.5.9. Central Nervous System Therapeutics Market - South Korea
      • 8.5.9.1. South Korea: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.5.9.2. South Korea: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.5.9.3. South Korea: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.5.10. Central Nervous System Therapeutics Market - Australia
      • 8.5.10.1. Australia: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.5.10.2. Australia: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.5.10.3. Australia: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.5.11. Central Nervous System Therapeutics Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.5.11.2. Rest of Asia Pacific: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.5.11.3. Rest of Asia Pacific: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • 8.6. Central Nervous System Therapeutics Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
    • 8.6.2. Middle East & Africa: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
    • 8.6.3. Middle East & Africa: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.6.4. Central Nervous System Therapeutics Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.6.4.2. Saudi Arabia: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.6.4.3. Saudi Arabia: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.6.5. Central Nervous System Therapeutics Market - UAE
      • 8.6.5.1. UAE: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.6.5.2. UAE: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.6.5.3. UAE: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.6.6. Central Nervous System Therapeutics Market - Israel
      • 8.6.6.1. Israel: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.6.6.2. Israel: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.6.6.3. Israel: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.6.7. Central Nervous System Therapeutics Market - South Africa
      • 8.6.7.1. South Africa: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.6.7.2. South Africa: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.6.7.3. South Africa: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.6.8. Central Nervous System Therapeutics Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.6.8.2. Rest of Middle East & Africa: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.6.8.3. Rest of Middle East & Africa: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • 8.7. Central Nervous System Therapeutics Market - Latin America
    • 8.7.1. Latin America: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
    • 8.7.2. Latin America: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
    • 8.7.3. Latin America: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.7.4. Central Nervous System Therapeutics Market - Mexico
      • 8.7.4.1. Mexico: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.7.4.2. Mexico: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.7.4.3. Mexico: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.7.5. Central Nervous System Therapeutics Market - Brazil
      • 8.7.5.1. Brazil: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.7.5.2. Brazil: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.7.5.3. Brazil: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.7.6. Central Nervous System Therapeutics Market - Argentina
      • 8.7.6.1. Argentina: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.7.6.2. Argentina: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.7.6.3. Argentina: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.7.7. Central Nervous System Therapeutics Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.7.7.2. Rest of Latin America: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.7.7.3. Rest of Latin America: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Biogen
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Otsuka Pharmaceutical Co., Ltd.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Eli Lilly and Company
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Merck & Co., Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Astra Zeneca
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Takeda Pharmaceutical Company Limited
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Novartis AG
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Teva Pharmaceutical Industries Ltd
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Johnson & Johnson, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Pfizer Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables:

  • Table 1 Global Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 2 Global Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 3 Global Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 4 North America: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 5 North America: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 6 North America: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 7 U.S.: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 8 U.S.: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 9 U.S.: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 10 Canada: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 11 Canada: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 12 Canada: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 13 Europe: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 14 Europe: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 15 Europe: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 16 UK: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 17 UK: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 18 UK: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 19 France: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 20 France: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 21 France: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 22 Germany: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 23 Germany: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 24 Germany: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 25 Italy: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 26 Italy: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 27 Italy: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 28 Spain: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 29 Spain: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 30 Spain: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 31 Netherlands: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 32 Netherlands: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 33 Netherlands: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 34 Russia: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 35 Russia: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 36 Russia: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 37 Rest of Europe: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 38 Rest of Europe: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 39 Rest of Europe: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 40 Asia Pacific: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 41 Asia Pacific: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 42 Asia Pacific: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 43 China: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 44 China: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 45 China: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 46 India: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 47 India: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 48 India: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 49 Malaysia: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 50 Malaysia: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 51 Malaysia: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 52 Japan: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 53 Japan: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 54 Japan: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 55 Indonesia: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 56 Indonesia: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 57 Indonesia: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 58 South Korea: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 59 South Korea: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 60 South Korea: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 61 Australia: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 62 Australia: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 63 Australia: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 64 Rest of Asia Pacific: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 65 Rest of Asia Pacific: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 66 Rest of Asia Pacific: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 67 Middle East & Africa: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 68 Middle East & Africa: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 69 Middle East & Africa: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 70 Saudi Arabia: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 71 Saudi Arabia: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 72 Saudi Arabia: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 73 UAE: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 74 UAE: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 75 UAE: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 76 Israel: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 77 Israel: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 78 Israel: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 79 South Africa: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 80 South Africa: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 81 South Africa: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 82 Rest of Middle East & Africa: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 83 Rest of Middle East & Africa: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 84 Rest of Middle East & Africa: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 85 Latin America: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 86 Latin America: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 87 Latin America: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 88 Mexico: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 89 Mexico: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 90 Mexico: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 91 Brazil: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 92 Brazil: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 93 Brazil: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 94 Argentina: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 95 Argentina: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 96 Argentina: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 97 Rest of Latin America: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 98 Rest of Latin America: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 99 Rest of Latin America: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)

List of Figures:

  • Figure 1. Global Central Nervous System Therapeutics Market, 2020-2034 (USD million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Disease
  • Figure 7. Global Central Nervous System Therapeutics Market, by Disease, 2024 & 2034 (USD million)
  • Figure 8. Market by Drug Class
  • Figure 9. Global Central Nervous System Therapeutics Market, by Drug Class, 2024 & 2034 (USD million)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Central Nervous System Therapeutics Market, by Distribution Channel, 2024 & 2034 (USD million)
  • Figure 12. Global Central Nervous System Therapeutics Market Assessment, By Geography, 2020-2034 (USD million)
  • Figure 13. Strategic Analysis - Global Central Nervous System Therapeutics Market